Switching between anti-tumour necrosis factors: trying to get a handle on a complex issue

被引：64

作者：

van Vollenhoven, Ronald F. ^{[1
]}

机构：

[1] Karolinska Univ Hosp, S-17176 Stockholm, Sweden

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2007年 / 66卷 / 07期

关键词：

D O I：

10.1136/ard.2007.069872

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：849 / 851

页数：3

共 26 条

[1]

Ang HTS, 2003, J RHEUMATOL, V30, P2315

[2]

BARTELDS GM, 2007, ANN RHEUM DIS

[3] Individualized monitoring of drug bioavailability and immunogenicity in rheumatoid arthritis patients treated with the tumor necrosis factor α inhibitor infliximab [J].

Bendtzen, Klaus ;

Geborek, Pierre ;

Svenson, Morten ;

Larsson, Lotta ;

Kapetanovic, Meliha C. ;

Saxne, Tore .

ARTHRITIS AND RHEUMATISM, 2006, 54 (12) :3782-3789

[4] Adalimumab in clinical practice. Outcome in 70 rheumatoid arthritis patients, including comparison of patients with and without previous anti-TNF exposure [J].

Bennett, AN ;

Peterson, P ;

Zain, A ;

Grumley, J ;

Panayi, G ;

Kirkham, B .

RHEUMATOLOGY, 2005, 44 (08) :1026-1031

[5]

Brocq O, 2002, PRESSE MED, V31, P1836

[6] True infliximab resistance in rheumatoid arthritis:: a role for lymphotoxin α? [J].

Buch, MH ;

Conaghan, PG ;

Quinn, MA ;

Bingham, SJ ;

Veale, D ;

Emery, P .

ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 (10) :1344-1346

[7]

Cohen G, 2005, CLIN EXP RHEUMATOL, V23, P795

[8]

Delaunay C, 2005, J RHEUMATOL, V32, P2183

[9] Anti-tumor necrosis factor α switching in rheumatoid arthritis and juvenile chronic arthritis [J].

Favalli, EG ;

Arreghini, M ;

Arnoldi, C ;

Panni, B ;

Marchesoni, A ;

Tosi, S ;

Pontikaki, I .

ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2004, 51 (02) :301-302

[10] Evidence for differential acquired drug resistance to anti-tumour necrosis factor agents in rheumatoid arthritis [J].

Finckh, A. ;

Simard, J. F. ;

Gabay, C. ;

Guerne, P. -A. .

ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 (06) :746-752

← 1 2 3 →